C
CytomX Therapeutics
Early-stage biotechnology company developing probodies, proteolytically-activated antibodies
At a glance
- Status
- Listed
- Listing
- IPO 2015
News
Open roles
CytomX Therapeutics in the South San Francisco ecosystem
The CytomX Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
- MPMike Panesis
- TATech Coast Angels
- PVPfizer Ventures
Canaan
Third Rock Ventures- RFRoche Venture Fund
- BPBVF Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former CytomX Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
RTR1 TherapeuticsEst. 2025
Krishna PoluUnited States
Charles FuchsUnited States
TTTrue North TherapeuticsEst. 2013
SESerImmuneEst. 2014
Patrick DaughertyUnited StatesPatents
80 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See CytomX Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

